Thousand Oaks – – October 29, 2026 -- Amgen (NASDAQ:AMGN) will report its third quarter 2026 financial results on Tuesday, November 3, 2026, after the close of U.S. financial markets.
Amgen schedules investor call for 4:30 p.m. ET with CEO Bradway
The earnings release will be followed by a conference call with the investment community at 4:30 p.m. ET. Robert A. Bradway, chairman and chief executive officer, will participate alongside other members of Amgen's senior management team.
Amgen streams the call live and archives the webcast for at least 90 days
Live audio of the call will be broadcast over the internet and is open to news media, investors and the general public. The webcast is available through the Investors section of Amgen's website, where the Investor Relations Events Calendar lists presentation times, webcast availability and links.
Amgen will keep the webcast archived for replay for at least 90 days after the event. The company is one of the 30 components of the Dow Jones Industrial Average and is part of the Nasdaq-100 Index.